- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Core Laboratories NV (CLB)
The Core Laboratories share price today is 9.010, view NYSE CLB stock exchange data. Track the latest Core Laboratories share price with real-time updates on CLB stock performance including market cap, day range, 52-week range and dividend yield. Access CLB charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.970
9.270
52 wk Range
8.610
20.360
CLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.9709.270
52 wk Range
8.61020.360
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
15.000
Upside
+66.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 19 consecutive years
Core Lab Q2 earnings miss analyst estimates- Investing.com
Form 13G Core Laboratories Inc. /DE/ For: 15 May- Investing.com
Form 4 Core Laboratories NV For: 5 October- Investing.com
- Form 4 Core Laboratories NV For: 5 October
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 15.000
(+66.48% Upside)
Core Laboratories NV Earnings Call Summary for Q3/2026
- Core Labs reported Q3 2026 EPS of $0.12, missing Wall Street's $0.32 forecast by 62.5%, though revenue rose 6% sequentially to $132.1M.
- Product sales surged 19% quarter-over-quarter while operating margin improved to 10% from 8%, with EBIT ex-items climbing 34% to $12.6M.
- Middle East conflict and Russia-Ukraine disruptions continued delaying projects; management sees broader global recovery emerging in 2027.
- Q4 guidance projects revenue of $128.5M-$134.5M and EPS of $0.12-$0.20, essentially flat with Q3 results at midpoint.
- Shares fell 2.38% after-hours to $10.24, near 52-week low of $9.13; net debt stands at $93.4M with leverage under 1.5x.
Last Updated: 29-10-2026, 06:48 pm
Read Full TranscriptEarnings
Latest Release
28-10-2026
EPS / Forecast
0.12 / 0.32
Revenue / Forecast
132.1M / --
Compare CLB to Peers and Sector
Metrics to compare | CLB | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipCLBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.8x | 38.5x | 4.7x | |
PEG Ratio | −0.54 | −0.46 | 0.00 | |
Price/Book | 1.5x | 1.9x | 1.1x | |
Price / LTM Sales | 0.8x | 1.3x | 1.3x | |
Upside (Analyst Target) | 66.3% | 31.7% | 34.8% | |
Fair Value Upside | Unlock | 7.5% | 10.1% | Unlock |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Core Laboratories (CLB) Share Price Today?
The Core Laboratories share price today is 9.010.
What is the current Core Laboratories (CLB) share price and day range?
As of 12-11-2026, the Core Laboratories share price is 9.010, with a previous close of 9.040. The share price has ranged from 8.970 to 9.270 today, while the 52-week range spans from 8.610 to 20.360.
What Is the Core Laboratories Market Cap?
As of today, Core Laboratories market cap is 414.010M.
Does Core Laboratories Pay Dividends? What's The Current Dividend Yield?
The Core Laboratories dividend yield is 0.4%%.
What Is the Core Laboratories (CLB) Share Price Target?
The average 12-month share price target for Core Laboratories is 15.000, with a high estimate of 21 and a low estimate of 11. 2 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +66.48% Upside potential.
What Is Core Laboratories's Earnings Per Share (TTM)?
The Core Laboratories EPS (TTM) is 0.34.
When Is the Next Core Laboratories Earnings Date?
Core Laboratories will release its next earnings report on 03-02-2027.
From a Technical Analysis Perspective, Is CLB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Core Laboratories Trade On?
Core Laboratories is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Core Laboratories?
The stock symbol for Core Laboratories is "CLB."
How Many Times Has Core Laboratories Stock Split?
Core Laboratories has split 2 times.
How Many Employees Does Core Laboratories Have?
Core Laboratories has 3300 employees.
What Is the CLB Premarket Price?
CLB's last pre-market stock price is 9.110. The pre-market share volume is 320.000, and the stock has changed by 0.070, or 0.770%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.